About Us

Open Innovation
Flexible business models to fit potential partner companies

Y-Biologics have open business model based on two platform technologies (Ymax-ABL, ALiCE) & Pipelines.
We are amenable to various partnerships, including out-licensing, research collaborations and co-development, especially
those companies with experience and expertise in the clinical development of bi-specific antibodies.

Platform Technology & Pipeline

  • Novel BsAb Platform
  • Antibody Pipeline in
    Various Modalities
  • Human Antibody

Business Models

  • Licensing
  • Co-development
  • Joint-Venture
  • Research Collaboration
Contact us
Use the contact form
below send us a message.
* indicates required field
  • +82-42-867-9971
  • +82-42-867-9970
  • somin@ybiologics.com